EUVIMEDEUVIMED entdecken
Crossref

Laparoscopic and Percutaneous Microwave Ablation for Hepatocellular Carcinoma—An Institutional Analysis of Complimentary Therapeutic Modalities

Bartholomew McKay iD, Edward Meehan, Lynn Chong, Ronan Motyer, Ashu Jhamb, Brett Knowles

World Journal of Surgery · 2025-06 · 49 (6) · 1564-1572

DOI: 10.1002/wjs.12612 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Surgery, online erschienen am 07.05.2025. Verfasst von Bartholomew McKay und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Upper GI & HPB Surgery, St. Vincent's Hospital, Fitzroy, Australia. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Laparoscopy, Microwaves. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Microwave ablation (MWA) is a locoregional thermoablative treatment for early HCC with equivalent outcomes to liver resection with reduced morbidity. Our study aimed to assess the oncological and perioperative outcomes of percutaneous and surgical MWA demonstrating their complementary utilization.

Methods

All patients undergoing percutaneous (pMWA) and surgical (sMWA) MWA for HCC at St Vincent's Hospital in Melbourne, Australia between August 2011 and April 2023 were included.

Results

140 microwave ablations occurred in 107 patients with a median follow‐up of 37.1 months (range 2.4–105.9 months). There were 51 pMWA and 56 sMWA cases, of which 53 were undertaken laparoscopically. Surgical ablations had a higher BCLC stage, and due to more instances of multiplicity, sMWA delivered more ablations and energy per lesion. This was associated with longer procedural time (69.5 min vs. 45 min and p < 0.001) and postoperative length of stay (1 day vs. 2 days and p < 0.001). Clavien–Dindo III or more complications were no different between the groups ( p = 0.404). Local recurrence was significantly higher in the percutaneous group (31.4% vs. 10.7% and p = 0.016), and multivariate analysis demonstrated that technique was a predictor of local recurrence (sMWA HR 0.22, 95% CI 0.08–0.65, and p = 0.006). The median disease‐free survival was 3.0 years (95% CI 2.6–NS) for sMWA and 1.7 years (95% CI 1.5–3.7) for pMWA, but the difference was not significant ( p = 0.36). There were insufficient events to calculate median overall survival for each group; however, no differences were observed with an overall 5‐year survival estimate of 0.64 (95% CI 0.54–0.77 and p = 0.86). Conclusion pMWA and sMWA are effective locoregional therapies for HCC. sMWA has the ability to deliver more energy per ablation with reduced local recurrence. However, overall survival is unaffected using the approach and both modalities should be used in a complimentary manner.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsCarcinoma, HepatocellularLaparoscopyMicrowavesRadiofrequency AblationAblation TechniquesCatheter AblationHumansMaleFemaleMiddle AgedAgedTreatment OutcomeRetrospective StudiesNeoplasm Recurrence, LocalAdultAged, 80 and overFollow-Up Studies

Stichwörter der Autor:innen

hepatocellular carcinomalaparoscopicmicrowave ablationpercutaneous

Autor:innen und Institutionen

  • Department of Upper GI & HPB Surgery, St. Vincent's Hospital, Fitzroy, Australia.
  • School of Medicine, University of Queensland, Herston, Australia.
  • Department of Medicine, Western Health, Footscray, Australia.
  • Department of Surgery, University of Melbourne, Fitzroy, Australia.
  • Department of Radiology, St. Vincent's Hospital, Fitzroy, Australia.

ORCID-Profile: Bartholomew McKay

Zitieren

APA

McKay, B., Meehan, E., Chong, L., Motyer, R., Jhamb, A., & Knowles, B. (2025). Laparoscopic and Percutaneous Microwave Ablation for Hepatocellular Carcinoma—An Institutional Analysis of Complimentary Therapeutic Modalities. World Journal of Surgery, 49(6), 1564-1572. https://doi.org/10.1002/wjs.12612

Vancouver

McKay B, Meehan E, Chong L, Motyer R, Jhamb A, Knowles B. Laparoscopic and Percutaneous Microwave Ablation for Hepatocellular Carcinoma—An Institutional Analysis of Complimentary Therapeutic Modalities. World Journal of Surgery. 2025;49(6):1564-1572. doi:10.1002/wjs.12612

BibTeX
@article{McKay2025,
  author = {McKay, Bartholomew and Meehan, Edward and Chong, Lynn and Motyer, Ronan and Jhamb, Ashu and Knowles, Brett},
  title = {Laparoscopic and Percutaneous Microwave Ablation for Hepatocellular Carcinoma—An Institutional Analysis of Complimentary Therapeutic Modalities},
  journal = {World Journal of Surgery},
  year = {2025},
  volume = {49},
  number = {6},
  pages = {1564--1572},
  doi = {10.1002/wjs.12612}
}
Kostenlos starten →